Literature DB >> 27665104

Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer.

Yeonjoo Choi1, Jin Won Kim2, Kyung Han Nam3, Song-Hee Han4, Ji-Won Kim1, Sang-Hoon Ahn5, Do Joong Park5, Keun-Wook Lee1, Hye Seung Lee4, Hyung-Ho Kim5.   

Abstract

BACKGROUND: The neutrophil-lymphocyte ratio (NLR) and the prognostic nutritional index (PNI) are markers of systemic inflammation known to be useful prognostic indicators of malignancy. However, little evidence has defined the influence of inflammation on the tumor microenvironment.
METHODS: Two hundred eighty-eight patients who underwent curative surgery for gastric cancer were included. Preoperative peripheral blood samples were used to analyze the NLR and PNI. The optimal cutoff levels for the NLR and PNI were defined by receiver operating characteristic curve analysis for survival (NLR = 2.7, PNI = 47.7). The densities of specific immune cells (CD3+, CD4+, CD8+) within the tumor microenvironment were measured in tumor microarrays by immunohistochemical analysis.
RESULTS: Two hundred thirty-five patients (81.6 %) had a low NLR and 53 patients (18.4 %) had a high NLR. One hundred seventeen patients (40.6 %) had a low PNI and 171 patients (59.4 %) had a high PNI. CD3+ and CD8+ immune cell density were not associated with the NLR and PNI. However, in the high-NLR group compared with the low-NLR group, CD4+ immune cell density was significantly decreased (P < 0.001). Similarly, the density of CD4+ immune cells was also significantly decreased in the low-PNI group compared with the high-PNI group (P = 0.007). A high NLR and a low PNI were correlated with worse overall survival in multivariate analysis (P = 0.028 and P = 0.002 respectively).
CONCLUSIONS: The NLR and PNI are associated with the density of CD4+ immune cells in the tumor microenvironment, which leads to prognostic values of systemic inflammation in gastric cancer.

Entities:  

Keywords:  Gastric cancer; Immune cell; Neutrophil–lymphocyte ratio; Prognostic nutritional index; Tumor microenvironment

Mesh:

Year:  2016        PMID: 27665104     DOI: 10.1007/s10120-016-0642-0

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN: 1436-3291            Impact factor:   7.370


  39 in total

Review 1.  Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment.

Authors:  Thomas F Gajewski; Mercedes Fuertes; Robbert Spaapen; Yan Zheng; Justin Kline
Journal:  Curr Opin Immunol       Date:  2010-12-23       Impact factor: 7.486

2.  Prognostic role of the tumor-associated tissue inflammatory reaction in transitional bladder cell carcinoma.

Authors:  Tommaso Cai; Gabriella Nesi; Vieri Boddi; Sandra Mazzoli; Maurizio Dal Canto; Riccardo Bartoletti
Journal:  Oncol Rep       Date:  2006-08       Impact factor: 3.906

3.  Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma.

Authors:  Tadahiro Nozoe; Mizuki Ninomiya; Takashi Maeda; Akito Matsukuma; Hideaki Nakashima; Takahiro Ezaki
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

Review 4.  Tumor-infiltrating T lymphocytes: friends or foes?

Authors:  Ping Yu; Yang-Xin Fu
Journal:  Lab Invest       Date:  2006-03       Impact factor: 5.662

5.  A novel clinically relevant strategy to abrogate autoimmunity and regulate alloimmunity in NOD mice.

Authors:  Andrea Vergani; Francesca D'Addio; Mollie Jurewicz; Alessandra Petrelli; Toshihiko Watanabe; Kaifeng Liu; Kenneth Law; Christian Schuetz; Michele Carvello; Elena Orsenigo; Shaoping Deng; Scott J Rodig; Javeed M Ansari; Carlo Staudacher; Reza Abdi; John Williams; James Markmann; Mark Atkinson; Mohamed H Sayegh; Paolo Fiorina
Journal:  Diabetes       Date:  2010-09       Impact factor: 9.461

6.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

7.  Immunological correlates of treatment and response in stage IV malignant melanoma patients treated with Ipilimumab.

Authors:  Jon Bjoern; Nikolaj Juul Nitschke; Trine Zeeberg Iversen; Henrik Schmidt; Kirsten Fode; Inge Marie Svane
Journal:  Oncoimmunology       Date:  2015-11-25       Impact factor: 8.110

Review 8.  Recent advances in immunopathophysiology of interleukin-6: an innovative therapeutic drug, tocilizumab (recombinant humanized anti-human interleukin-6 receptor antibody), unveils the mysterious etiology of immune-mediated inflammatory diseases.

Authors:  Yoshiyuki Ohsugi
Journal:  Biol Pharm Bull       Date:  2007-11       Impact factor: 2.233

Review 9.  Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human glioma.

Authors:  Gavin P Dunn; Ian F Dunn; William T Curry
Journal:  Cancer Immun       Date:  2007-08-13

10.  The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials.

Authors:  R Kumar; E Geuna; V Michalarea; M Guardascione; U Naumann; D Lorente; S B Kaye; J S de Bono
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

View more
  35 in total

1.  Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.

Authors:  Su-Jin Shin; Sang Yong Kim; Yoon Young Choi; Taeil Son; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh; Chung-Gyu Park; Hyoung-Il Kim
Journal:  Oncologist       Date:  2019-03-20

2.  Tumor-infiltrating γδT cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer.

Authors:  Jieti Wang; Chao Lin; He Li; Ruochen Li; Yifan Wu; Hao Liu; Heng Zhang; Hongyong He; Weijuan Zhang; Jiejie Xu
Journal:  Oncoimmunology       Date:  2017-07-24       Impact factor: 8.110

3.  Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin and Neutrophil-Lymphocyte Ratio in Gastric Cancer Patients.

Authors:  Hiroaki Saito; Yusuke Kono; Yuki Murakami; Yuji Shishido; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  World J Surg       Date:  2018-06       Impact factor: 3.352

4.  Combined analysis of the pre- and postoperative neutrophil-lymphocyte ratio predicts the outcomes of patients with gastric cancer.

Authors:  Kozo Miyatani; Hiroaki Saito; Yusuke Kono; Yuki Murakami; Hirohiko Kuroda; Tomoyuki Matsunaga; Yoji Fukumoto; Tomohiro Osaki; Keigo Ashida; Yoshiyuki Fujiwara
Journal:  Surg Today       Date:  2017-09-15       Impact factor: 2.549

5.  Pre-treatment Peripheral Neutrophil-Lymphocyte Ratio as a Prognostic Marker in Gastric Cancer.

Authors:  Monika Magdy; Tarek Hussein; Ahmed Ezzat; Ahmed Gaballah
Journal:  J Gastrointest Cancer       Date:  2019-12

6.  The T-Cell-Inflammation Status Can Predict Outcomes of Adjuvant Chemotherapy in Patients with Gastric Cancer.

Authors:  Xiaolong Wu; Xiangyu Gao; Xiaofang Xing; Xianzi Wen; Ziyu Li; Jiafu Ji
Journal:  Ann Surg Oncol       Date:  2020-08-07       Impact factor: 5.344

7.  High postoperative neutrophil-lymphocyte ratio and low preoperative lymphocyte-monocyte ratio predict poor prognosis in gastric cancer patients receiving gastrectomy with positive lavage cytology: a retrospective cohort study.

Authors:  Sho Sato; Chikara Kunisaki; Masazumi Takahashi; Hirokazu Kubo; Nobuhiro Tsuchiya; Kei Sato; Hiroshi Miyamoto; Yuko Tamura; Hiroki Kondo; Yusaku Tanaka; Kohei Kasahara; Takashi Kosaka; Hirotoshi Akiyama; Yusuke Saigusa; Itaru Endo
Journal:  Langenbecks Arch Surg       Date:  2021-06-17       Impact factor: 3.445

8.  Combination of preoperative red cell distribution width and neutrophil to lymphocyte ratio as a prognostic marker for gastric cancer patients.

Authors:  Lei Fu; Qian Li; Qingxia Fan
Journal:  J Gastrointest Oncol       Date:  2021-06

9.  Early myelostimulation in patients with locally advanced gastric cancer after fluorouracil plus platinum-based neoadjuvant chemotherapy is related to poor prognosis.

Authors:  Yang Liu; Yongde Cao; Leting Xiao; Haijiang Wang
Journal:  Cancer Chemother Pharmacol       Date:  2021-02-21       Impact factor: 3.333

10.  Association of Lymphocyte-to-Monocyte Ratio With Survival in Advanced Gastric Cancer Patients Treated With Immune Checkpoint Inhibitor.

Authors:  Yang Chen; Cheng Zhang; Zhi Peng; Changsong Qi; Jifang Gong; Xiaotian Zhang; Jian Li; Lin Shen
Journal:  Front Oncol       Date:  2021-06-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.